Odimma Therapeutics participated in the 23rd SACHS Annual Biotech in Europe Forum held in Basel on September 20–21, 2023.
The company was selected to present during the Rising Stars session, highlighting Odimma Therapeutics among emerging biotechnology innovators developing next-generation healthcare solutions.
The forum brings together biotechnology companies, investors, pharmaceutical leaders and strategic partners from across the international life sciences ecosystem.
Participation in the event further supported Odimma Therapeutics’ international visibility as the company continues advancing its personalized immunotherapy platform combining AI-driven neoantigen selection and synthetic DNA technologies.
